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Hedamycin is an antitumor polyketide antibiotic with
unusual biosynthetic features. Earlier sequence anal-
ysis of the hedamycin biosynthetic gene cluster
implied a role for type I and type II polyketide syn-
thases (PKSs). We demonstrate that the hedamycin
minimal PKS can synthesize a dodecaketide back-
bone. The ketosynthase (KS) subunit of this PKS
has specificity for both type I and type II acyl carrier
proteins (ACPs) with which it collaborates during
chain initiation and chain elongation, respectively.
The KS receives a C6 primer unit from the terminal
ACP domain of HedU (a type I PKS protein) directly
and subsequently interacts with the ACP domain of
HedE (a type II PKS protein) during the process of
chain elongation. HedE is a bifunctional protein
with both ACP and aromatase activity. Its aromatase
domain can modulate the chain length specificity of
theminimal PKS. Chain length can also be influenced
by HedA, the C-9 ketoreductase. While co-expres-
sion of the hedamycin minimal PKS and a chain-
initiation module from the R1128 PKS yields an iso-
butyryl-primed decaketide, the orthologous PKS
subunits from the hedamycin gene cluster itself are
unable to prime the minimal PKS with a nonacetyl
starter unit. Our findings provide new insights into
the mechanism of chain initiation and elongation by
type II PKSs.
INTRODUCTION
The actinomycetes produce a variety of structurally complex
aromatic antibiotics that use type II polyketide synthases
(PKSs), a family of mechanistically related multifunctional
enzymes (O’Hagan, 1991; Ridley and Khosla, 2009). Every type
II PKS includes a core module of subunits called the ‘‘minimal
PKS,’’ which consists of the ketosynthase-chain length factor
(KS-CLF) heterodimer, an acyl carrier protein (ACP), and a ma-
lonyl-CoA:ACP transacylase (MAT) that is typically shared by
multiple PKSs and fatty acid synthases in the bacterium
(although the MAT is required for minimal PKS activity, it is notChemistry & Biology 16, 1197–12encoded within the PKS gene cluster) (Carreras et al., 1996;
Summers et al., 1995). The minimal PKS synthesizes a highly
reactive poly-b-ketothioester intermediate, which is subse-
quently acted upon by downstream enzymes to yield a polycyclic
natural product (Das and Khosla, 2009; Hertweck, 2009; Shen,
2000). In many cases, (e.g., actinorhodin (act) (Carreras and
Khosla, 1998) and tetracenomycin (tcm) (Bao et al., 1998)
(Figure 1)), biosynthesis of this poly-b-ketothioester intermediate
is primed by an acetyl unit (derived from the decarboxylation of
a malonyl-ACP thioester) and elongated by a defined number
of malonyl units (also supplied as malonyl-ACP substrates)
through the iterative action of the KS-CLF (Dreier and Khosla,
2000; Dreier et al., 1999).
In other cases, the presence of a dedicated PKS initiation
module leads to the formation of a nonacetyl-derived diketide
that is then elongated by the KS-CLF (Hertweck et al., 2007;
Moore and Hertweck, 2002). For example, the initiation module
of the doxorubicin (dps) PKS (Grimm et al., 1994) synthesizes
a propionyl-CoA derived b-ketopentanoyl-ACP intermediate,
whereas the R1128 (zhu) initiation module catalyzes formation
of a butanoyl-, pentanoyl-, hexanoyl-, or 4-methylpentanoyl-
ACP thioester (Marti et al., 2000) (Figure 1). The polyketide back-
bones of yet other aromatic antibiotics, such as hedamycin (hed)
(Bililign et al., 2004) and fredericamycin A (fdm) (Wendt-Pienkow-
ski et al., 2005) (Figure 1), are initiated by even more complex
mechanisms that remain to be elucidated.
Two key characteristics of type II PKSs that harbor dedicated
initiation modules are: (i) orthogonal protein-protein specificity of
KS and ACP partners from the initiation and the elongation
modules of the bimodular PKS (Tang et al., 2003a); and (ii) an inti-
mate connection between primer unit selection and chain-length
specificity (Tang et al., 2004b, 2004c). The goal of this study was
to gain a deeper understanding of the mechanisms of chain initi-
ation and elongation of the hedamycin PKS, which apparently
involves an unusual combination of a type I and a type II PKS
systems (Bililign et al., 2004).
Hedamycin (7) (Figure 1), an aromatic polyketide with anti-
cancer activity (Bradner et al., 1966; Joel and Goldberg, 1970),
is produced by Streptomyces griseoruber (Schmitz et al., 1966)
and consists of a planar 4H-anthra[1,2-b]pyran polycyclic agly-
cone with a bisepoxide side chain (Sequin et al., 1977). It also
harbors two aminosugars attached via C-glycoside linkages
(Sequin et al., 1977). The unusual side chain of hedamycin is
important for its anticancer activity (Hansen et al., 1995; Owen
et al., 2002; Pavlopoulos et al., 1999; Tu et al., 2005), and07, November 25, 2009 ª2009 Elsevier Ltd All rights reserved 1197
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Analysis of the Hemadycin Polyketide SynthaseFigure 1. Structures of Acetyl and Non-acetyl Primed Aromatic Polyketides
The starter unit in each polyketide molecule is highlighted in red.presumably corresponds to the start of the polyketide backbone
(Bililign et al., 2004). Cloning, sequencing, and knockout analysis
of the hedamycin gene cluster (Figure 2A) has revealed the
involvement of an atypical multimodular (type I) PKS comprised
of the HedT and HedU proteins in aglycone biosynthesis (Bililign
et al., 2004). HedT consists of a ‘‘KSq’’ domain responsible for
the decarboxylative priming of the polyketide pathway (Bisang
et al., 1999; Butler et al., 2001; Kakavas et al., 1997; Leadlay
et al., 2001), an AT (acyl transferase) and an ACP domain, and
has been proposed to serve as the priming module (Moore and
Hertweck, 2002). HedU includes two KS domains, an AT, an
ACP, a ketoreductase (KR), and a dehydratase (DH) domain. It
has been proposed to catalyze two rounds of chain elongation
using the acetyl primer unit supplied by HedT. Each chain elon-
gation cycle is followed by b-ketoreduction and dehydration,
leading to biosynthesis of an unsaturated 2,4-hexadienyl inter-
mediate that is then transferred onto the minimal PKS. Disruption
of hedT abolished the production of hedamycin, suggesting that
these type I PKS proteins are involved in hedamycin biosynthesis
(Bililign et al., 2004).
More typical for an aromatic polyketide gene cluster, the heda-
mycin gene cluster also encodes subunits that comprise the
minimal PKS—a KS (HedC), a CLF (HedD), and an ACP (HedE)
(Figure 2A). HedE is a bifunctional protein with an aromatase
and an ACP domain. The aromatase domain of HedE is believed
to catalyze the aromatization of the first six-membered ring
formed during hedamycin biosynthesis. Also encoded within
the gene cluster is HedA, a homolog of the actIII gene that
encodes the C-9 specific KR in actinorhodin biosynthesis
(Crump et al., 1997; Korman et al., 2004). By analogy, it is
thought to catalyze reduction of the C-9 carbonyl in the nascent
polyketide backbone.
Intriguingly, the gene cluster also encodes a stand-alone
homodimeric KS (HedS) and an acyl-ACP thioesterase (AATE,
HedF), similar to the components found in the initiation modules
of the doxorubicin, and R1128 PKSs (Figure 2B and Table 1).
HedS, a homolog of the ketosynthase III (KSIII) found in bacterial
fatty acid synthases (Rock and Cronan, 1996), is also similar to
DpsC in the doxorubicin PKS (Rajgarhia et al., 2001) and ZhuH1198 Chemistry & Biology 16, 1197–1207, November 25, 2009 ª200in the R1128 synthase (Figure 2C) (Meadows and Khosla,
2001). HedF is homologous to DpsD and ZhuC, both acyl-ACP
thioestearases (AATEs) that hydrolyze acetyl-primed ACPs as
a proofreading mechanism (Figure 2C) (Tang et al., 2004a).
Thus, the hedamycin gene cluster is the only reported bacterial
PKS that incorporates elements of type I and type II PKSs. Our
studies, involving experiments in vivo and in vitro, provide new
insights into the mechanism and specificity of this unusual PKS.
RESULTS
In Vivo Properties of the Hedamycin Minimal PKS
A series of 12 plasmids (Table 2) containing selected combina-
tions of PKS subunit genes were constructed, and their product
profiles were analyzed in the heterologous host Streptomyces
coelicolor CH999 (McDaniel et al., 1993a). It was unclear at first
whether the hedamycin minimal PKS would behave like the
R1128-minimal PKS, which does not produce polyketides in
the absence of a suitable initiation module (C.K., unpublished
data) or the frenolicin minimal PKS, which synthesizes polyketide
products derived exclusively from malonyl-CoA in the absence
of an initiation module (McDaniel et al., 1993b). To resolve this
matter, two constructs were prepared harboring the hed minimal
PKS genes with (pAD181) or without (pAD259) hedS and hedF,
homologs of ZhuH (KSIII) and ZhuC (AATE) (Table 1), respec-
tively. Both constructs also encode a C-9 specific ketoreductase
(KR) (act KR or HedA). LC/MS and NMR analysis revealed
that the same four acetyl-primed polyketides were produced
by both strains as major products (8-11) (Figure 3). Feeding
S. coelicolor CH999/pAD181 with precursors of alternative
CoA thioesters (e.g., propionic acid, norvaline or DL-aminobuty-
ric acid (Tang et al., 2004b)), also did not yield any nonacetyl-
primed product. Detailed comparative analysis of the product
profiles of the two strains failed to reveal significant differences
in relative and absolute yield of products, suggesting that by
themselves, neither HedS nor HedF can influence the priming
mechanism of the polyketide chain (Table 1).
The dodecaketide (C-24) AD211a (8) (10 mg/l) was isolated
from a fraction extracted with ethyl acetate/acetic acid (99:1).9 Elsevier Ltd All rights reserved
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Analysis of the Hemadycin Polyketide SynthaseFigure 2. Comparison of the Hemadycin and R1139 Initiation Modules and Minimal PKS Genes
(A) Organization of relevant genes in the hedamycin gene cluster, which encodes both type I and type II PKS genes as shown in gray and black, respectively.
(B) Organization of relevant genes in the R1128 gene cluster. The genes are not drawn to scale. The sequences of homologous proteins in the two gene clusters
were aligned; their identity/similarity is reported in Table 1.
(C) Known mechanisms for chain initiation and elongation in the R1128 PKS. The initiation and elongation modules of this PKS are shown in separate boxes.
MAT, malonyl-CoA:ACP transacylase; KR, ketoreductase; DH, Ddehydratase; ER, enoyl reductase.LC/MS analysis revealed a mass of 435 and 433 in ESI-MS posi-
tive and ESI-MS negative modes, respectively. HR-ESI-MS
confirmed that AD211a has the molecular formula C24H18O8
(observed m/z 457.0899 [M + Na]+, calcd. m/z 457.0922
for C24H18O8Na). The structure of this previously unknown
compound was unambiguously solved by 1H and 13C NMR
spectroscopic analysis (Table 3), as well as HSQC, COSY and
HMBC NMR experiments (see Supplemental Data available on-
line). 1H NMR showed the characteristic doublet-doublet peaks
of H9 and doublet peaks of H8 and H10, all of which are coupled
through COSY, suggesting that AD211a is C-9 reduced polyke-
tide that has undergone a C7-C12 cyclization. Notably, the heda-
mycin aglycone also has an equivalent C7-C12 cyclized
aromatic ring. Based on an earlier precedent, we anticipated
that the ARO domain of the full-length HedE protein plays
a role in AD211a biosynthesis (McDaniel et al., 1994b). To verify
this activity of HedE, S. coelicolor CH999/pAD174 expressing
the act KS-CLF and KR genes along with HedE was constructed
and analyzed. Whereas the act KS-CLF, ACP and KR are known
to synthesize mutactin and dehydromutactin (McDaniel et al.,Chemistry & Biology 16, 1197–121994a), inclusion of either the act ARO (McDaniel et al., 1994b)
or the full-length HedE (CH999/pAD174) led to the isolation of
SEK34 (12) and SEK34b (13).
The structure of AD211a (8) also establishes that the hedamy-
cin KS-CLF is capable of synthesizing a dodecaketide back-
bone, consistent with the known structure of the hedamycin
aglycone. Like other KS-CLF heterodimers, it too can control
the chain-length specificity by monitoring the length of the
carbon-chain backbone, not the number of elongation cycles
(Nicholson et al., 2003; Tang et al., 2003b). However, as dis-
cussed below, other PKS components can modulate the chain
length specificity of the hed KS-CLF.
In addition to AD211a, two undecaketides, TW94b (9) and
TW94c (10), were also isolated from S. coelicolor CH999/
pAD181 and S. coelicolor CH999/pAD259 in an approximately
2:1 ratio from the fraction extracted with ethyl acetate/methanol
(90:10). In an earlier report, TW94b was proposed to be con-
verted enzymatically into the optically active (at C-14) furanone
analog TW94c (Yu et al., 1998). The concomitant production of
both undecaketides and dodecaketides by the hed KS-CLF is07, November 25, 2009 ª2009 Elsevier Ltd All rights reserved 1199
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pathways (Yu et al., 1998), and suggests that the hedamycin
enzyme also has relaxed chain-length specificity. Furthermore,
replacing HedE with the stand-alone ACP domain from HedE
(S.coelicolor CH999/pAD236 and S. coelicolor CH999/pAD258)
led to selective disappearance of dodecaketide 8. Thus, the
functional ARO domain of HedE is able to modulate the chain-
length specificity of the KS-CLF by catalyzing the formation of
an aromatic ring, as reported earlier in the cases of the whiE
(Shen et al., 1999; Yu et al., 1998), act, fren (McDaniel et al.,
1994b; Nicholson et al., 2003) and oxytetracycline (otc) (Petkovic
et al., 1999) PKSs.
Unexpectedly, the fourth product of these two constructs was
the reduced tetraketide pyrone 11 (Gruschow et al., 2007).
Although its yield was lower than the other compounds
(1.2 mg/l), its structure sheds new light on a fundamental prop-
erty of the act KR that has been previously debated but never
definitively established (Ma et al., 2008; McDaniel et al., 1993b).
Specifically, it has been unclear whether regiospecific ketore-
duction occurs on a partially elongated b-ketothioester interme-
diate or after formation of the full-length nascent chain. The fact
that 11 harbors a hydroxyl group at C-7 suggests that the KR is
able to catalyze reduction even before a full-length polyketide
chain is formed. Furthermore, replacement of the hed KR by
the act KR (S. coelicolor CH999/pAD211) did not change the
product profile or the relative and absolute yields of the prod-
ucts, indicating that the two proteins are functionally inter-
changeable.
To investigate the possible influence of the hed KR (HedA) on
chain length, a control plasmid encoding the hed minimal PKS
without the KR was constructed and analyzed in S. coelicolor
CH999. Removal of KR leads to an entirely different product
profile. S. coelicolor CH999/pAD212 expressing the minimal
hed PKS produces compounds 14, 15, 16, 17, and 18, whose
structures were characterized by 1H, 13C NMR analysis, and
LC/MS analysis (Supplemental Data). Compound 14 is a triketide
Table 1. Deduced Functions and Sequence Comparison of
Hedamycin and R1128 PKS Genes
Hedamycin
Gene
R1128
Gene
Identity,
Similarity
(%)a Proposed Function
hedC zhuB 63, 17 ketosynthase (KS)
hedD zhuA 51, 16 chain-length factor (CLF)
hedSb zhuH 20, 18 ketosynthase III (KSIII)
hedFb zhuC 47, 14 acyl-ACP thioesterase (AATE)
hedE bifunctional aromatase/acyl
carrier protein (ARO/ACP)
hedE ACP zhuN 46, 26 ACP
hedE ARO/ACP modified ARO/ACP
hedA ketoreductase (KR)
hedT type I enzyme
hedU type I enzyme
hedU ACP zhuG 25, 22 priming ACP
a Identity and similarity was calculated using ClustalW multiple alignment
sequence server.
b No activity observed for these genes in vivo.1200 Chemistry & Biology 16, 1197–1207, November 25, 2009 ª200pyrone (Xie et al., 2006), and the tetraketide pyrone 15 (Abe et al.,
2005) is the unreduced analog of 11. Compound 16 is a pentake-
tide, 17 is an undecaketide, and 18 is a dodecaketide reported
earlier (Yu et al., 1998) in a construct expressing the whiE
minimal PKS. Compound 17 was the major product (8 mg/l)
from S. coelicolor CH999/pAD212, whereas compound 18 was
isolated in lower quantity (2 mg/l) and the yield of 14, 15, and
16 was 1-2 mg/l. Consistent with the findings reported above,
inclusion of hedS and hedF (S. coelicolor CH999/pAD175) did
not lead to the production of nonacetyl-primed polyketide prod-
ucts (Table 2).
In Vitro Characterization of the Hedamycin Minimal PKS
To investigate the properties of the hedamycin minimal PKS hed
KS-CLF, the stand-alone ACP domain of HedE, the bifunctional
ARO/ACP derivative of HedE and S. coelicolor MAT were puri-
fied (Figure S1), as described in the Experimental Procedures.
The identity of each of these proteins was verified by mass
spectrometry (Table S5). [14C]-Malonyl-CoA was incubated
with various combinations of these purified proteins to identify
possible covalent intermediates formed during the PKS catalytic
cycle (Figure 4). When purified holo-ACP (lane 1), MAT (lane 2), or
KS-CLF (lane 3) were incubated individually with [14C]-malonyl-
CoA, both MAT (21 Ci/mol) and ACP (15 Ci/mol) were labeled
strongly. Labeling of the KS-CLF was considerably weaker
(2 Ci/mol). Co-incubation of ACP (15 Ci/mol) and MAT (19 Ci/mol)
with [14C]-malonyl-CoA (lane 4) did not increase the label inten-
sity on the ACP, suggesting that under non-turnover conditions,
the ACP is saturated even in the absence of MAT. This is typical
of certain type II ACPs that possess an intrinsic self-malonylation
property (Arthur et al., 2005; Hitchman et al., 1998). When holo-
ACP (11 Ci/mol) and KS-CLF (11 Ci/mol) (lane 5) were co-incu-
bated with [14C]-malonyl-CoA, both proteins were labeled. Add-
ing MAT (19 Ci/mol) to this mixture (lane 6) further enhanced the
label intensity on both ACP (28 Ci/mol) and KS-CLF (26 Ci/mol),
presumably due to the increased rate of chain elongation.
Table 2. Plasmid Constructions and the Resulting Polyketide
Products
Plasmida KS-CLF ACP(s) Auxiliary KR
Polyketide
Products
pAD181 hed hedE hedF, hedS actIII 8, 9, 10, 11
pAD259 hed hedE hedA 8, 9, 10, 11
pAD211 hed hedE actIII 8, 9, 10, 11
pAD258 hed hedE(ACP) hedA 9, 10, 11
pAD236 hed hedE(ACP) actIII 9, 10, 11
pAD174 act hedE hedF,hedS actIII 12, 13
pAD212 hed hedE 14, 15, 16, 17, 18
pAD175 hed hedE hedF,hedS 14, 15, 16, 17, 18
pAD185 hed zhuN R1128 IM No Product
pAD188 hed zhuN R1128 IM actIII No Product
pAD180 hed actI actIV, actVII actIII No Product
pAD281 hed hedE R1128 IM 14, 15, 16, 19
a Each plasmid is a derivative of pRM5. The constructs were transformed
into S. coelicolor CH999/pBOOST*. Products were analyzed by LC-MS
and NMR spectroscopy. IM, initiation module.9 Elsevier Ltd All rights reserved
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KS was labeled in the presence of MAT (Carreras and Khosla,
1998; Meurer and Hutchinson, 1995), we also observed weak
labeling of the hed CLF. Whether this species corresponds to
an on-path covalent intermediate or not remains to be estab-
lished. Overall, our results verify both the requirement of the
KS, CLF, holo-ACP, and MAT for polyketide synthesis from
malonyl-CoA, as well as the sequence of intermediates formed
in the initial catalytic cycle.
The recognition between an ACP and a KS is essential for
polyketide biosynthesis. Although most KS-CLF and ACP
subunits from type II PKSs are interchangeable (Khosla et al.,
1992, 1993; Sherman et al., 1992), there are exceptions. For
example, ACPs are not exchangeable between initiation and
elongation PKS modules (Tang et al., 2003a). Also for example,
the ketosynthases of the initiation and elongation modules of
the R1128 PKS have orthogonal specificity for their designated
ACPs (i.e., ZhuG is unable to participate in chain elongation,
whereas ZhuN cannot initiate chain synthesis) (Figure 2C).
Also, KS-CLF and ACP subunits from antibiotic and spore
pigment polyketide pathways have orthogonal specificity (Lee
et al., 2005). We therefore tested the ability of several purified
holo-ACP proteins from type II PKSs (Figure S1) to catalyze
chain growth with the hed KS-CLF. When HedE was replaced
with ZhuN (lane 1), FrenN (lane 2), or FdmH (lane 3), three repre-
sentative ACP proteins derived from the elongation modules of
the R1128, frenolicin and fredericamycin PKSs, respectively, no
labeling of the hed KS was observed in the presence of MAT
and [14C]-malonyl-CoA (Figure S2). In all cases the individual
ACP proteins were labeled, confirming their intrinsic activity.
The same result was verified in vivo when hed KS-CLF was
Figure 3. Structure of Polyketide Products Isolated
from Different Recombinant Strains
co-expressed with the act ACP (S. coelicolor
CH999/pAD180) or ZhuN (S. coelicolor CH999/
pAD185andS.coelicolorCH999/pAD188) (Table2).
None of these constructs produced detectable
quantities of any polyketide. Thus it appears that
the hed KS-CLF is able to discriminate between its
cognate ACP (HedE) and orthologs from other
minimal PKSs of antibiotic biosynthetic pathways,
and suggests that these heterodimeric enzymes
have more complex protein recognition features
than had been anticipated earlier.
The absence of any influence of HedS or HedF on
chain initiation or elongation led us to favor
a biosynthetic model in which the type I PKS en-
coded by HedT and HedU was responsible for
synthesizing the 2,4-hexadienyl primer unit of the
hedamycin aglycone and directly priming the KS-
CLF with it. However, neither HedT nor HedU could
be expressed and purified to homogeneity from
E. coli or S. coelicolor CH999 (data not shown).
We therefore expressed and purified the ACP
domain from the C-terminal end of HedU as an
apo-protein (Supplemental Data). By way of
comparison, two apo-ACP proteins from well-studied PKS initi-
ation modules (ZhuG and FrenJ from R1128 and frenolicin
biosynthetic pathways, respectively) were also prepared. The
apo-ACPs were directly converted into the corresponding
[14C]-hexanoyl-ACP by the phosphopantetheinyl transferase
Sfp, as described in the Experimental Procedures, which in
turn were incubated with the hed KS-CLF as shown in Figure 5.
Due to the unavailability of [14C]-2,4-hexadienyl CoA, [14C]-hex-
anoyl CoA was used as a surrogate primer unit. Whereas 2 mM
of [14C]-hexanoyl-ZhuG (lane 3) and [14C]-hexanoyl-HedU ACP
(lane 2) were able to efficiently transfer the acyl chain onto hed
KS-CLF, [14C]-hexanoyl-FrenJ (lane 4) could do so less effi-
ciently. Thus, hed KS-CLF also appears to have some speci-
ficity for ACP subunits involved in the biosynthesis and transfer
of nonacetyl primer units. The observed labeling of hed KS-CLF
by HedU also supports the hypothesis that HedS and HedF are
not required for chain transfer between the (type I) PKS initia-
tion module and the (type II) PKS elongation module of this
unusual polyketide pathway. Notably, weak labeling of the
hed KS-CLF was observed only upon prolonged incubation
with a high (100 mM) concentration of [14C]-hexanoyl-CoA
(lane 1). Such a high concentration of hexanoyl-CoA is unlikely
to be available in vivo and suggests that a dedicated initiation
module is required to initiate hedamycin biosynthesis. Consis-
tent with this observation and in contrast to other KS-CLF
enzymes, acyl-CoA precursors such as propionic acid, DL-ami-
nobutyric acid, and norvaline (Tang et al., 2004b) were unable
to prime the biosynthesis of new polyketides, even when added
to S. coelicolor CH999/pAD211 and S. coelicolor CH999/
pAD212 at high concentrations ranging from 1-4 g/l (data not
shown).Chemistry & Biology 16, 1197–1207, November 25, 2009 ª2009 Elsevier Ltd All rights reserved 1201
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the ACP domains of initiation and elongation modules, HedE
ARO/ACP was added after labeling the hed KS-CLF with [14C]-
hexanoyl-ZhuG (Figure 6). No labeling of the ARO/ACP was
observed in the absence of the KS-CLF (lane 1). When hed
KS-CLF was added, chain transfer was readily observed (lane
3). No transacylation was observed when [14C]-hexanoyl HedU
ACP and HedE ARO/ACP were co-incubated by themselves
(data not shown). Thus a model for chain growth can be derived
(Figure 7) in which the hed KS-CLF first receives the primer
unit from the ACP domain of HedU and only then engages with
HedE to catalyze further chain elongation.
In Vivo Demonstration of Interaction between the
Hedamycin Minimal PKS and an Initiation Module
The above data suggested that the hed KS-CLF could accept
nonacetyl primer units only from selected initiation modules.
Due to our inability to express the type I PKS proteins from the
hedamycin PKS in E. coli or S. coelicolor, and guided by our
in vitro data summarized above, we tested this hypothesis with
the R1128 initiation module. Indeed, coexpression of the
Table 3. 1H and 13C NMR Data for AD211a (8) and AD281a (19)
AD211a (8) AD281a (19)
No. 13C 1H 13C 1H
1 159.2 160.7
2 89.6 5.37 (d, J = 1.7, 1H) 88.3 5.14 (d, J = 1.7, 1H)
3 169.8 170.2
4 108.7 6.03 (d, J = 1.7) 100.5 5.56 (d, J = 1.7, 1H)
5 154.2 159.1
6 48.5 4.16 (s, 2H) 47.2 3.5 (s, 2H)
7 134.7 136.9
8 109.1 6.76 (d, J = 6.8, 1H) 119.4 6.21 (d, J = 1.8, 1H)
9 128.7 7.28 (dd,
J = 6.8,7.1, 1H)
160.5
10 116.6 6.94 (d, J = 7.1, 1H) 99.6 6.08 (d, J = 1.8, 1H)
11 157 164.7
12 119.5 108.3
13 202.9 199.7
14 119.5 110.1
15 134.6 163.5
16 105.1 6.06 (d, J = 1.6, 1H) 102.9 6.06 (d, J = 3.6, 1H)
17 163.9 160.2
18 100.2 6.17 (d, J = 1.6, 1H) 100.3 6.15 (d, J = 3.6, 1H)
19 160.4 144.7
20 102.8 36.8 2.18 (t, 2H)
21 155.3 30.9 1.2 (m, 2H)
22 113.2 6.63 (s,1H) 27.7 1.2 (m, 1H)
23, 230 138 22.2 0.79 (d, J = 0.54, 6H)
24 19.9 1.95 (s, 3H)
1H and 13C NMR data were recorded in DMSO-d6 (500 MHz for
1H and
125 MHz for 13C). Chemical shifts are reported in d (ppm). Coupling
constants are reported in Hz. Carbons are labeled according to their
number in polyketide backbone.1202 Chemistry & Biology 16, 1197–1207, November 25, 2009 ª200R1128 initiation module with the hed minimal PKS (S. coelicolor
CH999/pAD281) led to the production of an isobutyryl primed
product, AD281a (19). The structure of AD281a was confirmed
by 1H and 13C NMR spectroscopic analysis (Table 3) as well as
HSQC, COSY and HMBC NMR experiments (Supplemental
Data). HR-ESI-MS confirmed that AD281a has the molecular
formula C24H24O8 (observed m/z 463.1369 [M + Na]
+, calcd.
m/z 463.1371 for C24H24O8Na). AD281a is an analog of SEK15
(Fu et al., 1994) and verifies two predictable features of the hed
minimal PKS: (i) that it exercises chain length control by moni-
toring the length of the carbon chain backbone; and (ii) that it
can be primed by the R1128 ACP to synthesize a C-24 back-
bone. Interestingly, AD281a shows C7-C12 cyclization pattern,
which may be due to the aromatase activity of HedE.
Figure 4. Autoradiogram of a 4%–12% SDS-PAGE Gel Showing
Labeling of Purified PKS Proteins by [14C]-malonyl-CoA
Lane 1, holo-HedE ACP only; lane 2, fabD MAT only; lane 3, hed KS-CLF only;
lane 4, holo-HedE ACP + MAT; lane 5, holo-HedE ACP + KS-CLF; lane 6, holo-
HedE ACP + MAT + KS-CLF. For quantitative estimates of radiolabeling inten-
sities of individual bands (errors 2%–3%), see text.
Figure 5. Autoradiograph of Gel Showing the Labeling of KS-CLF in
the Presence of Alternative Hexanoyl Donors
Lane 1, [14C]-hexanoyl-CoA; lane 2, [14C]-hexanoyl-HedU; lane 3, [14C]-hexa-
noyl-ZhuG; lane 4: [14C]-hexanoyl-FrenJ.9 Elsevier Ltd All rights reserved
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The hedamycin PKS gene cluster reported by Thorson and
coworkers illustrated a fundamentally new and unusual principle
for priming a polyketide derived from a type II PKS (Bililign et al.,
2004). Specifically, it was proposed that a type I PKS from the
hedamycin gene cluster is involved in synthesizing the unsatu-
rated primer unit. Our results have verified that the hed minimal
PKS is indeed a dodecaketide synthase, although it can also
synthesize undecaketides. Minimal PKS activity is not obligately
dependent upon a functional initiation module. Unlike the R1128
PKS, the KSIII and AATE homologs of the hedamycin gene
cluster do not appear to be involved in chain initiation; instead,
hedamycin biosynthesis is primed by HedU, possibly in collabo-
ration with HedT. Our data also shows that HedE is a bifunctional
protein with ACP and ARO activity, and that the hed KR is similar
to act KR. Both the hed ARO and the hed KR are able to modu-
late the chain length specificity of the KS-CLF, as illustrated by
variable ratios of undecaketide and dodecaketide products in
the presence or absence of these auxiliary PKS subunits. The
hed KS-CLF heterodimer has specificity for its ACP partners
(i.e., the HedU ACP domain during chain transfer and the HedE
ACP domain during chain elongation), and shows a greater
ability to discriminate against heterologous ACPs than most
homologous enzymes investigated thus far. Coexpression of
R1128 initiation module and the hed minimal PKS leads to the
synthesis of isobutyryl primed polyketide product. Together,
our results demonstrate that the hedamycin polyketide synthase
is an interesting model system that warrants further genetic,
biochemical, and structural investigations.
SIGNIFICANCE
Mechanistic analysis of unusual PKSs is essential to under-
stand the molecular basis for polyketide natural product
diversity. It has also enabled the engineered biosynthesis
of ‘‘unnatural’’ natural products. The results of our in vitro
and in vivo studies on the hedamycin PKS highlight its
typical and atypical characteristics, and emphasize its rele-
Figure 6. Autoradiograph of Gel Showing KS-CLF Catalyzed
Labeling of Elongation Holo-ACP
Lane 1, [14C]-hexanoyl-ZhuG and HedE ARO/ACP; lane 2, [14C]-hexanoyl-
ZhuG and hed KS-CLF; lane 3, [14C]-hexanoyl-ZhuG, HedE ARO/ACP and
hed KS-CLF.Chemistry & Biology 16, 1197–120vance to fundamental and applied studies involving type I
and type II PKSs. In particular, our findings reported here
have at least two implications worthy of further pursuit.
First, structural and mechanistic studies are warranted to
understand how the hed KS-CLF accommodates two ACP
domains from HedU and HedE, while at the same time
discriminating against an unusually wide range of heterolo-
gous ACP subunits. Second, now that the biosynthetic rele-
vance of the type I-type II PKS interface in the hedamycin
pathway has been firmly established, more detailed investi-
gations into this unusual recognition interface promise to
reveal fundamentally new opportunities for harnessing the
catalytic potential of both major subclasses of PKSs to
synthesize novel polyketides.
EXPERIMENTAL PROCEDURES
Materials
Radio-labeled coenzyme A (CoA) substrates were purchased from American
Radiolabeled Chemicals (St. Louis, MO). FLAG peptide was purchased from
Genscript (Piscataway, NJ). Corp. Anti-FLAG M2 monoclonal antibody, anti-
FLAG M1 agarose affinity gel, and all other biochemicals, including unlabeled
CoA substrates, were from Sigma-Aldrich, Inc. (St. Louis, MO). Hi-Trap
Q anion-exchange column was from Amersham Biosciences (now GE
Healthcare, Piscataway, NJ). Precast SDS-PAGE gels were from Invitrogen
(Carlsbad, CA). PCR was performed using PfuTurbo Hotstart polymerase
(Stratagene, La Jolla, CA), and amplimers were sequence verified prior to
further use. All cloning steps were performed in E. coli XL1-Blue and E. coli
TOP10. Unmethylated DNA was obtained by passaging plasmids through
the methylase-deficient strain E. coli ET12567. Genomic DNA from Strepto-
myces griseoruber was prepared using QIAGEN Genomic DNA Purification
Kit (Qiagen Corp., Valencia, CA). Protoplast preparation and PEG-assisted
transformation were performed as described Kieser et al. (2000). S. coelicolor
CH999 and E. coli strains BL21(DE3) or BAP1 were used for protein expres-
sion. Plasmids used for cloning included pCR-BLUNT (Invitrogen), pUC18
(New England Biolabs, Ipswich, MA) and pET28b (Novagen, Gibbstown, NJ).
The deuterated solvents for NMR experiments were purchased from Cam-
bridge Isotope Laboratories, Inc (Andover, MA) and all other solvents were
purchased from Fisher Scientific (Bridgewater, NJ) at highest available grade.
Cloning of Hedamycin Genes
The hed PKS genes, hedC, hedD, hedE and hedA, were amplified by PCR
using S. griseoruber genomic DNA as the template (Bililign, et al., 2004). The
primers used were hedC_FP: GGTCTAGAttaattaaGGAGGACCCATATGGTCC
GAGACACGCCCCGCAGG and hedC_RP: GGACTAGTTCATGCGGGCCGTC
CCGGAGCCGT; hedD_FP: GGTCTAGAGGAGGACCCATATGGACTACAAG
GACGACGACGACAAGATGAGCGACGCGCTGATCACGGGC and hedD_RP:
GGACTAGTTCAACCGCCAGGTCGCCGAGGCCG; hedE_FP: GGTCTAGAG
GAGGACCCATATGGGCGGCTCCTGGACCTTGGAG and hedE_RP: GGACT
AGTTCAGGCGGCCTCGGCGACCTGGCGGTT; hedA_FP: GGTCTAGAGGA
GGACCCATATGTCCCGTCCCCAGACCGCCTTCGT and hedA_RP: GGAA
TTACTAGTTCAGTAGTTGCCCAGGCCGCCGCAGAC. Restriction sites are
indicated in italics or in lowercase, ribosomal binding sites are in bold, and
the underlined sequence corresponds to the FLAG tag. PCR amplimers
were cloned into the pCR-BLUNT vector, and their DNA sequences were veri-
fied. The genes were then assembled as synthetic operons in pUC18 prior to
transfer into a pRM5-derived shuttle vector. The first gene in each operon was
inserted between the XbaI and EcoRI sites in pUC18; subsequent genes were
inserted downstream following SpeI/EcoRI digestion of the vector and XbaI/
EcoRI digestion of the insert. To do so, we took advantage of the naturally
occurring EcoRI site in the pCR-BLUNT vector. The complete operon was iso-
lated by PacI/EcoRI digestion, and inserted between the PacI/EcoRI sites of
the S. coelicolor/E. coli shuttle vectors pRM5 (which carries the act ketoreduc-
tase gene) or pSEK4 (which lacks this KR gene) (McDaniel et al., 1993a), dis-
placing the act PKS genes (Table 2). For construction of plasmids that harbor7, November 25, 2009 ª2009 Elsevier Ltd All rights reserved 1203
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Analysis of the Hemadycin Polyketide SynthaseFigure 7. Proposed Pathway for Hedamycin BiosynthesisR1128 PKS genes, pYT45 and pYT81 were used as cloning vectors (Tang
et al., 2004b; 2004c). The resulting plasmids were introduced via protoplast
transformation into Streptomyces coelicolor CH999 (McDaniel et al., 1993a)
containing the plasmid pBOOST* (Hu et al., 2003).
Culture Conditions and Small-Scale Fermentation Analysis
The strains were grown on R5 agar plates (Kieser et al., 2000) containing
50 mg/l thiostrepton and 100 mg/l of apramycin at 30C for 7 days. For
HPLC analysis, the pigmented agar medium from 10-12 plates was mashed
and extracted first with methanol/ethyl acetate (10:90) and then with acetic
acid/ethyl acetate (1:99). The solvent was evaporated in vacuo and the residue
was dissolved in methanol. The mixture was analyzed by reverse-phase HPLC
outfitted with a UV-Vis detector at 280 and 410 nm, using an Apollo C18 column
(250 mm 3 4.6 mm). A linear gradient from 30% acetonitrile (MeCN) in water
(0.1% TFA) to 55% MeCN in water (0.1% TFA) was used over 40 min with
a flow rate of 1 mL/min. LC/MS of the same crude extract was performed by
electrospray ionization (both positive and negative ionization). For precursor
directed biosynthesis experiments, acyl-CoA precursors such as sodium
propionate, DL-aminobutyric acid and norvaline were added while preparing
the media at a concentration of 1-4 g/l when needed (Tang et al., 2004c).1204 Chemistry & Biology 16, 1197–1207, November 25, 2009 ª2009Large-Scale Production, Isolation, and Characterization
of Polyketide Products
For preparative scale studies, the above fermentation and crude extract prep-
aration procedures were scaled up to 3-4 L of R5 agar medium. The extract
was dried with toluene, and the solvent was removed in vacuo. The crude
extract was flashed through a silica gel column using 1% acetic acid in ethyl
acetate. The eluate was dried, redissolved in 3-4 ml methanol, and injected
onto the preparative reverse-phase HPLC column (250 mm 3 22 mm, C18
column, Vydac). Gradients used included 10%–40% MeCN in water (0.1%
TFA) over 80 min or 20%–60% MeCN in water (0.1% TFA) over 100 min,
with a flow rate of 5 ml/min. Purified fractions were dried in vacuo or by lyoph-
ilization. In cases where further purification was warranted, the relevant HPLC
fraction was redissolved in 0.5-1 ml acetone and applied to a preparative TLC
plate, which was developed in a suitable solvent system consisting of ethyl
acetate and hexane with or without 1% acetic acid. 1H and 13C NMR spectra
of purified polyketide products were recorded on Varian Inova 500. The 1H
NMR spectra were referenced at 2.49 ppm in DMSO-d6. The
13C NMR
spectra were referenced at 39.5 ppm in DMSO-d6. Single-bond
1H-13C,
multiple-bond 1H-1H and 1H-13C connectivity was determined by HSQC,
COSY and HMBC respectively on Varian Inova-600 NMR instruments. The
1H and 13C NMR assignments are summarized in Table 3 and SupplementalElsevier Ltd All rights reserved
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Vincent Coates Foundation Mass Spectrometry Laboratory at Stanford
University.
Expression and Purification of the Hedamycin KS-CLF
S. coelicolorCH999/pAD211 was used to express and purify hed KS-CLF. The
plasmid pAD211 encoded the KS, the CLF, the bifunctional HedE ACP/aroma-
tase and the act KR. The CLF protein harbored a FLAG-tag at its N terminus to
facilitate purification of the tightly associated KS-CLF heterodimer. Spores
were inoculated into 50 ml R5 liquid medium, and grown for 2 days at 30C.
The seed culture (25 ml) was transferred to 0.5 l SMM medium containing
50 mg/l thiostrepton and 100 mg/l apramycin, and grown further with vigorous
shaking for 48 hr. Mycelia were collected by centrifugation, resuspended in
25 ml disruption buffer (200 mM Na2HPO4, 200 mM NaCl, 2.5 mM DTT,
1.5 mM benzamidine, 2.5 mM EDTA, 2 mg/L pepstatin, 2 mg/L leupeptin,
30% v/v glycerol, pH 7.0), and lysed by sonication. The insoluble cell debris
was removed by centrifugation. Subsequently, DNA was also removed by
adding 0.2% polyethyleneimine (PEI) and centrifuging. The proteins in the re-
sulting supernatant were precipitated by adding 30% (NH4)2SO4 followed by
50% (NH4)2SO4. The protein mixture in the 30%–50% (NH4)2SO4 cut was re-
dissolved in 30ml TBS buffer [50 mM Tris (pH 7.4), 0.15 mM NaCl and
10 mM CaCl2], filtered through 0.45 mm filter, and loaded onto a column
packed with anti-FLAG M1 agarose affinity gel (1 ml). The column was washed
with 10 ml of TBS, and KS-CLF was eluted with 5 3 1 ml of TBS containing
100 mg/mL 3 3 FLAG peptide. The eluent was concentrated and buffer
exchanged into 100 mM NaH2PO4, 2 mM DTT, 2 mM EDTA, 20% Glycerol
(pH 7.4), aliquoted, flash-frozen with liquid nitrogen, and stored at 80C.
The protein concentration was determined by the Bradford method with the
Bio-Rad protein kit. The yield of hed KS-CLF was 1-2 mg/l culture volume.
Construction, Expression, and Purification of HedE
and Its Derivatives
HedE is a unique PKS subunit that consists of a partial aromatase (ARO)
domain at the N terminus, followed by an intact ARO domain and an ACP
domain. Attempts to express the intact HedE protein in E. coli were unsuc-
cessful. We therefore constructed two additional expression plasmids con-
taining the ACP domain alone (identified by sequence analysis with other
type II ACPs) and a bifunctional protein consisting of the intact ARO and
ACP domains (ARO/ACP). The two genes were amplified using the primers
hedE_ACP_FP: GGAATTCATATGATGGCCGAACTGACCCTCGACGAGCTCA
AG, hedE_ACP_RP: GGAATTACTAGTTCAGGCGGCCTCGGCGACCTGGCG
GTTGAC and hedE_ARO/ACP_FP: GGGGCATATGGCCGACACCGAGACCG
TCTCCGGC, hedE_ARO/ACP_RP: GGACTAGTGCGGGCGGCGTGCGGC
GAGGCCCA. These PCR products were cloned into pET28b to yield pAD58
and pAD227, respectively. The genes were expressed in an engineered
E. coli strain BAP1 (Pfeifer et al., 2001) to obtain the pantetheinylated (holo)
forms of the corresponding proteins. Protein expression was induced at an
O.D.600nm of 0.6 with 200 mM IPTG and allowed to proceed at 18
C for
18 hr. Cells were harvested and lysed by sonication. The proteins were initially
purified on Ni-NTA resin (QIAGEN). After loading the protein, the Ni-NTA resin
was washed with buffer containing 20 mM imidazole, 300 mM NaCl, 50 mM
NaH2PO4 (pH 8.0). The protein was then eluted with buffer containing
200 mM imidazole, 300 mM NaCl, 50 mM NaH2PO4 (pH 8.0). This was followed
by anion-exchange chromatography on a Hi-Trap Q column (from 0 to 100% of
1M NaCl in 60 min, proteins elute between 200 and 300 mM NaCl). Purified
proteins were buffer exchanged into 100 mM sodium phosphate, 20% glycerol
(pH 7.2) and stored at 80C. The relative ratio of the holo and apo forms of
ACP was quantified by LC-MS; in each case, the ACP was found to be nearly
100% in the holo form. Protein concentrations were determined by the Brad-
ford method with the Bio-Rad protein kit. No expression of HedE was
observed however from E. coli BAP1 or E. coli BL21(DE3) strains. Typical yield
of each protein was between 10-12 mg/l.
Expression and Purification of Other Acyl Carrier Proteins
A variety of other ACPs from initiation and elongation modules of type II PKSs
were used in this study. All of the elongation ACPs were expressed and purified
from E. coli BAP1 to obtain exclusively the proteins in holo form. The ACPs
were then purified by Ni-NTA affinity column. Expression strains E. coliChemistry & Biology 16, 1197–12BAP1/pGS1, BAP1/pESM11 (Meadows and Khosla, 2001), and BAP1/
pAD191 were used to obtain FrenN (the ACP from the elongation module of
the frenolicin PKS), ZhuN (ACP from the elongation module of the R1128
PKS) and FdmH (ACP from the fredericamycin PKS), respectively. The yield
of each protein was in the range of 15-20 mg/l.
To prepare acyl-ACP forms of FrenJ (from the initiation module of the freno-
licin PKS) and ZhuG (from the initiation module of the R1128 PKS), the proteins
were first expressed and purified from E. coli BL21(DE3) cell line to obtain apo-
ACPs exclusively. ZhuG was from BL21(DE3)/pESM10 E. coli expression
strain (Meadows and Khosla, 2001), whereas FrenJ was from BL21(DE3)/
pYT21(Tang et al., 2003a).
To investigate the role of HedU in hedamycin biosynthesis, the terminal ACP
domain of this type I PKS protein was amplified. The boundary of this ACP
domain was identified by aligning the sequence of HedU with module 1-6 of
DEBS PKS (Chen et al., 2007). The ACP domain was amplified by PCR using
the primers hedUACP_FP: GGAATTCATATGCGGCTCGCCGGCCGGTCCG
AGGCGGAG and hedUACP_RP: GGAATTACTAGT TCATGCGGGGTGCAGC
AGTTCCGCGAGGTG. The PCR product was digested with NdeI/SpeI and
ligated into a pET28b derivative to yield pAD64. The His6-tagged protein
was expressed in E. coli strain BL21(DE3) to obtain apo-form of the protein.
Protein expression was induced at an O.D.600nm of 0.6 with 200 mM IPTG
and allowed to proceed at 20C for 20 hr. The purification method was similar
to that for the HedE ACP. The protein yield was 12 mg/l.
Expression and Purification of MAT and Sfp Proteins
S. coelicolor MAT was expressed from E.coli BL21(DE3)/pGFL16 and purified
as described previously (Carreras and Khosla, 1998). To prepare acyl-ACP
proteins, the broad specificity phosphopantetheinyl transferase Sfp (Lambalot
et al., 1996; Quadri et al., 1998) was purified and used as described earlier
(Dreier and Khosla, 2000). For example, conversion of an apo-ACP to [14C]-
hexanoyl-S-ACP was carried out in buffer containing sodium phosphate, pH
7.0 and 10 mM MgCl2 (Tang et al., 2004a). Apo-ACP, Sfp and [
14C]-hexanoyl
CoA were added to the final concentrations of 120, 10, and 300 mM, respec-
tively, in a reaction volume of 200 ml. After overnight incubation at room
temperature, the mixture was diluted to 2.5 ml with the reaction buffer and
loaded onto a PD-10 desalting column (Amersham, now GE Healthcare) that
had been pre-equilibrated with the reaction buffer. Acyl-ACPs were eluted
within the first 3.5 mL, and concentrated with 3000 Da MWCO spin column
(Amicon Ultra, Millipore) to 20 ml. Then 1 ml of the final concentrate was applied
to a SDS-PAGE gel, and the amount of radioactivity was quantified by autora-
diography to calculate the effective concentration of the hexanoyl-ACP.
Labeled acyl-ACP proteins were stored at 20C.
Detection of Covalently Bound Protein Intermediates
in Polyketide Biosynthesis
To investigate chain initiation and elongation in vitro, selected protein combi-
nations were incubated with radio-labeled substrates and analyzed via radio-
SDS-PAGE. For example, a PKS reaction mixture (12 ml) contained 200 mM
[14C]malonyl CoA (55Ci/mol), 10 mM the hed KS-CLF, 40-50 mM holo-ACP,
and 1-5 mM MAT in a buffer containing 100 mM sodium phosphate, pH 7.3,
2 mM EDTA, 2 mM DTT. Following incubation at room temperature for
8-14 min, the reaction was quenched with 6 ml of non-reducing sample buffer
(0.1% bromophenol blue, 1% SDS, 40% glycerol), and loaded directly onto
a 4%–12% SDS-PAGE. Following staining, dried gels were subjected to auto-
radiography.
To assay the ability of hed KS-CLF to accept nonacetyl primer units, the
purified heterodimer was incubated with alternative [14C]-hexanoyl-S-ACPs
or [14C]-hexanoyl CoA. 10 mM KS-CLF was incubated with 2 mM [14C]-hexa-
noyl-S-ACP (27 Ci/mol) or 100 mM [14C]-hexanoyl CoA (27Ci/mol) in a reaction
buffer (12 ml) containing 100 mM sodium phosphate, pH 7.3, 2 mM EDTA,
2 mM DTT for 30 min at RT. The reaction was quenched by adding 6 ml of
non-reducing sample buffer, and loaded directly onto 4%–12% SDS-PAGE.
Following staining, dried gels were subjected to autoradiography.
To investigate whether the hed KS-CLF can catalyze transfer of a nonacetyl
primer from an ACP of an initiation module to the HedE (elongation module)
ACP, 10 mM KS-CLF was incubated with 2 mM of [14C]hexanoyl-S-ZhuG
(27 Ci/mol) in reaction buffer (12 ml) containing 100 mM sodium phosphate,
pH 7.3, 2 mM EDTA, 2 mM DTT for 30 min at room temperature. Thereafter,07, November 25, 2009 ª2009 Elsevier Ltd All rights reserved 1205
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for another 15 min. As a control, 2 mM of [14C]-hexanoyl-S-ZhuG (27 Ci/mol)
was incubated separately with the hed KS-CLF or HedE for the same amount
of time.
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